David L Paterson Selected Research

Carbapenems (Carbapenem Antibiotics)

5/2022	Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting.
5/2022	Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis.
1/2022	Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.
1/2022	All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies.
1/2022	Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
12/2021	Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis.
11/2021	An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
8/2021	Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2).
4/2021	Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial.
3/2021	PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David L Paterson Research Topics

Disease

111	Infections 07/2022 - 12/2002
58	Sepsis (Septicemia) 05/2022 - 12/2002
24	Critical Illness (Critically Ill) 01/2022 - 06/2004
13	Bacteremia 08/2022 - 01/2004
11	Urinary Tract Infections (Urinary Tract Infection) 05/2022 - 07/2009
10	Pneumonia (Pneumonitis) 01/2021 - 07/2004
9	Intraabdominal Infections 12/2020 - 07/2006
7	AIDS-Related Complex (ARC) 01/2021 - 01/2010
6	Cross Infection (Nosocomial Infection) 01/2015 - 01/2004
5	Aspergillosis 12/2010 - 01/2003
4	Ventilator-Associated Pneumonia 01/2022 - 03/2005
4	Healthcare-Associated Pneumonia 12/2021 - 09/2010
4	Bacterial Infections (Bacterial Infection) 11/2021 - 06/2004
4	Septic Shock (Toxic Shock Syndrome) 01/2017 - 08/2007
3	Gram-Negative Bacterial Infections 04/2022 - 09/2006
3	Respiratory Sounds (Crackle) 01/2022 - 01/2018
3	Wounds and Injuries (Trauma) 07/2014 - 07/2008
3	Communicable Diseases (Infectious Diseases) 04/2009 - 09/2006
2	Wound Infection (Wound Infections) 03/2022 - 11/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 11/2020
2	Gram-Positive Bacterial Infections 03/2022 - 01/2014
2	COVID-19 01/2022 - 10/2020
2	Pseudomonas Infections 01/2022 - 11/2007
2	Shock 12/2021 - 10/2016
2	Acute Kidney Injury (Acute Renal Failure) 11/2020 - 11/2017
2	Body Weight (Weight, Body) 12/2019 - 01/2018
2	Clostridium Infections 02/2017 - 01/2017
2	Nocardia Infections 11/2016 - 05/2007
2	Meningitis 11/2015 - 04/2009
2	Dementia (Dementias) 06/2015 - 07/2014
2	Cystic Fibrosis (Mucoviscidosis) 04/2015 - 07/2009
2	Escherichia coli Infections 02/2015 - 01/2014
2	Burns 09/2014 - 08/2012
2	Human Influenza (Influenza) 10/2011 - 11/2009
2	Enterobacteriaceae Infections 06/2006 - 06/2006

Drug/Important Bio-Agent (IBA)

71	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 05/2004
38	Carbapenems (Carbapenem Antibiotics)IBA 05/2022 - 07/2004
18	Pharmaceutical PreparationsIBA 03/2022 - 05/2004
17	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022 - 12/2007
16	LactamsIBA 01/2022 - 11/2013
15	Meropenem (Merrem)FDA LinkGeneric 01/2022 - 06/2004
14	Colistin (Coly-Mycin)FDA Link 03/2022 - 09/2006
13	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2022 - 05/2004
12	beta-Lactamases (beta-Lactamase)IBA 04/2021 - 01/2004
9	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 03/2022 - 01/2004
9	CreatinineIBA 01/2021 - 01/2015
8	Polymyxins (Polymyxin)IBA 03/2022 - 09/2006
8	beta-LactamsIBA 01/2020 - 09/2006
7	carbapenemaseIBA 05/2022 - 04/2012
7	Vancomycin FDA LinkGeneric 11/2020 - 02/2008
6	Cefepime (Maxipime)FDA LinkGeneric 11/2021 - 10/2005
5	CefiderocolIBA 04/2022 - 10/2020
5	Piperacillin FDA LinkGeneric 01/2022 - 07/2013
5	Tigecycline (Tygacil)FDA Link 01/2022 - 01/2007
5	FluoroquinolonesIBA 07/2014 - 08/2007
4	AminoglycosidesIBA 01/2022 - 03/2007
4	Third Generation CephalosporinsIBA 04/2021 - 12/2002
4	Daptomycin FDA Link 11/2020 - 01/2008
4	Anti-Infective Agents (Microbicides)IBA 10/2015 - 01/2006
4	beta Lactam AntibioticsIBA 09/2013 - 01/2004
3	Tobramycin (Nebcin)FDA LinkGeneric 01/2022 - 01/2018
3	tazobactam drug combination ceftolozaneIBA 01/2022 - 01/2017
3	beta-Lactamase InhibitorsIBA 01/2020 - 02/2008
3	Ceftazidime (Fortum)FDA LinkGeneric 01/2020 - 01/2004
3	QuinolonesIBA 02/2016 - 05/2004
3	Linezolid (Zyvox)FDA Link 01/2014 - 12/2007
2	TetracyclinesIBA 01/2022 - 01/2002
2	Amikacin (A.M.K)FDA LinkGeneric 01/2022 - 07/2006
2	Antifungal AgentsIBA 10/2021 - 01/2005
2	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2021 - 12/2010
2	ceftazidime drug combination avibactamIBA 12/2020 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 08/2007
2	Ertapenem (Invanz)FDA Link 01/2016 - 03/2013
2	Cefotaxime (Kendrick)FDA LinkGeneric 01/2015 - 01/2004
2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 11/2013 - 02/2011
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 06/2013 - 05/2007
2	VaccinesIBA 01/2013 - 10/2012
2	Aztreonam FDA LinkGeneric 02/2011 - 01/2004
2	AntigensIBA 05/2007 - 05/2005
2	EnzymesIBA 05/2007 - 11/2004
2	galactomannanIBA 05/2007 - 05/2005
2	Alemtuzumab (Campath)FDA Link 01/2007 - 10/2006
1	ZincIBA 03/2022
1	temocillinIBA 03/2022

Therapy/Procedure

61	Therapeutics 08/2022 - 01/2002
7	Length of Stay 04/2021 - 03/2005
7	Catheters 12/2019 - 01/2009
5	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2017 - 07/2009
5	Transplantation 02/2017 - 01/2003
3	Central Venous Catheters 04/2017 - 01/2009
3	Liver Transplantation 06/2003 - 01/2003
2	Debridement 07/2022 - 03/2022
2	Mechanical Ventilators (Ventilator) 01/2022 - 01/2022
2	Antibiotic Prophylaxis 07/2013 - 06/2003
2	Critical Care (Surgical Intensive Care) 11/2009 - 07/2008
2	Peritoneal Dialysis 07/2009 - 03/2005
2	Colectomy 03/2007 - 03/2005
1	Duration of Therapy 08/2022
1	Replacement Arthroplasty 07/2022
1	Prostheses and Implants (Prosthesis) 03/2022